EpimAb Biotherapeutics raised $74M Series B venture round, led by Dongfang Li.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
SDIC FundLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$219M
Top Valuation
-
EpimAb Biotherapeutics raised $74M in a Series B round.
The round was announced on 06/05/19.
The round was led by Dongfang Li, Cheng Xing.